Ruijin Neurobank of Alzheimer's Disease and Dementia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ruijin Neurobank of Alzheimer's Disease and Dementia — Stella

View on ClinicalTrials.gov

Recruiting

Back to Dementia trials

Trial locations(1 site)

China

Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality

Key details

Sponsor

Ruijin Hospital

Enrollment target

~400 participants

Started

November 2021

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

50 Years – 90 Years

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.